Clinical Trial Update: GCB-002 in Treatment of Patients With Rett Syndrome [NA]

View source ↗

Summary

This document reports an ongoing clinical trial evaluating GCB-002 for Rett syndrome with MECP2 mutation. Enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• GCB-002

Snippet

Sponsor: Genecombio Ltd. | Conditions: RETT Syndrome With Proven MECP2 Mutation | NA | Status: ENROLLING_BY_INVITATION